» Articles » PMID: 35328335

Neuroprotective Effect of Luteolin-7-O-Glucoside Against 6-OHDA-Induced Damage in Undifferentiated and RA-Differentiated SH-SY5Y Cells

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2022 Mar 25
PMID 35328335
Authors
Affiliations
Soon will be listed here.
Abstract

Luteolin is one of the most common flavonoids present in edible plants and its potential benefits to the central nervous system include decrease of microglia activation, neuronal damage and high antioxidant properties. The aim of this research was to evaluate the neuroprotective, antioxidant and anti-inflammatory activities of luteolin-7-O-glucoside (Lut7). Undifferentiated and retinoic acid (RA)-differentiated SH-SY5Y cells were pretreated with Lut7 and incubated with 6-hydroxydopamine (6-OHDA). Cytotoxic and neuroprotective effects were determined by MTT assay. Antioxidant capacity was determined by DPPH, FRAP, and ORAC assays. ROS production, mitochondrial membrane potential (ΔΨm), Caspase-3 activity, acetylcholinesterase inhibition (AChEI) and nuclear damage were also determined in SH-SY5Y cells. TNF-α, IL-6 and IL-10 release were evaluated in LPS-induced RAW264.7 cells by ELISA. In undifferentiated SH-SY5Y cells, Lut7 increased cell viability after 24 h, while in RA-differentiated SH-SY5Y cells, Lut7 increased cell viability after 24 and 48 h. Lut7 showed a high antioxidant activity when compared with synthetic antioxidants. In undifferentiated cells, Lut7 prevented mitochondrial membrane depolarization induced by 6-OHDA treatment, decreased Caspase-3 and AChE activity, and inhibited nuclear condensation and fragmentation. In LPS-stimulated RAW264.7 cells, Lut7 treatment reduced TNF-α levels and increased IL-10 levels after 3 and 24 h, respectively. In summary, the results suggest that Lut7 has neuroprotective effects, thus, further studies should be considered to validate its pharmacological potential in more complex models, aiming the treatment of neurodegenerative diseases.

Citing Articles

Beneficial Antioxidant Effects of Coenzyme Q10 in In Vitro and In Vivo Models of CDKL5 Deficiency Disorder.

Loi M, Valenti F, Medici G, Mottolese N, Candini G, Bove A Int J Mol Sci. 2025; 26(5).

PMID: 40076840 PMC: 11900000. DOI: 10.3390/ijms26052204.


Polyphenols, Alkaloids, and Terpenoids Against Neurodegeneration: Evaluating the Neuroprotective Effects of Phytocompounds Through a Comprehensive Review of the Current Evidence.

de Lima E, Fornari Laurindo L, Cavallari Strozze Catharin V, Direito R, Tanaka M, Jasmin Santos German I Metabolites. 2025; 15(2).

PMID: 39997749 PMC: 11857241. DOI: 10.3390/metabo15020124.


Unlocking the potential of luteolin: A natural migraine management approach through network pharmacology.

Rushendran R, Vellapandian C J Tradit Complement Med. 2025; 14(6):611-621.

PMID: 39850605 PMC: 11752114. DOI: 10.1016/j.jtcme.2024.04.011.


Ameliorating Effect of Fermented on Sleep Deprivation-Induced Cognitive Impairment Through Antioxidant and BDNF Signaling in Mice.

Seo C, Lee B, Jee H, Yoo J, Lee C, Park J Nutrients. 2024; 16(23).

PMID: 39683616 PMC: 11644480. DOI: 10.3390/nu16234224.


Network pharmacology‑based analysis and experimental verification of the inhibitory role of luteoloside on gastric cancer cells via the p53/p21 pathway.

Lin X, Yang P, Li X, Xu Z, Wu H, Hu S Oncol Lett. 2024; 29(2):76.

PMID: 39650229 PMC: 11622105. DOI: 10.3892/ol.2024.14822.


References
1.
Chauhan D, Li G, Hideshima T, Podar K, Mitsiades C, Mitsiades N . JNK-dependent release of mitochondrial protein, Smac, during apoptosis in multiple myeloma (MM) cells. J Biol Chem. 2003; 278(20):17593-6. DOI: 10.1074/jbc.C300076200. View

2.
Palombo R, Savini I, Avigliano L, Madonna S, Cavani A, Albanesi C . Luteolin-7-glucoside inhibits IL-22/STAT3 pathway, reducing proliferation, acanthosis, and inflammation in keratinocytes and in mouse psoriatic model. Cell Death Dis. 2016; 7(8):e2344. PMC: 5108310. DOI: 10.1038/cddis.2016.201. View

3.
Korshunov S, Skulachev V, Starkov A . High protonic potential actuates a mechanism of production of reactive oxygen species in mitochondria. FEBS Lett. 1997; 416(1):15-8. DOI: 10.1016/s0014-5793(97)01159-9. View

4.
Krishna A, Biryukov M, Trefois C, Antony P, Hussong R, Lin J . Systems genomics evaluation of the SH-SY5Y neuroblastoma cell line as a model for Parkinson's disease. BMC Genomics. 2014; 15:1154. PMC: 4367834. DOI: 10.1186/1471-2164-15-1154. View

5.
Pinteus S, Silva J, Alves C, Horta A, Fino N, Rodrigues A . Cytoprotective effect of seaweeds with high antioxidant activity from the Peniche coast (Portugal). Food Chem. 2016; 218:591-599. DOI: 10.1016/j.foodchem.2016.09.067. View